Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Alternative cancer treatments Stories

2014-02-11 12:26:43

Recurrent lung cancer responds to Integrative Immunotherapy SCOTTSDALE, Ariz., Feb. 11, 2014 /PRNewswire/ -- Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. To view the multimedia assets associated with this release, please visit...

2014-01-08 12:30:29

HOUSTON, Jan. 8, 2014 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the preliminary response to the allegations in the lawsuit filed by Texas Medical Board (TMB) at the Texas State Office of Administrative Hearing on December 11, 2013 against Stanislaw R. Burzynski, M.D., Ph.D. (SRB). The allegations claim that SRB used internet-based advertising regarding antineoplastons (ANP), and that it was false, misleading, and violated federal law. The allegations can be divided...

2013-12-05 12:29:29

A REAL OPTION FOR STANDARD THERAPY-RESISTANT CANCERS SCOTTSDALE, Ariz., Dec. 5, 2013 /PRNewswire/ -- In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes. To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers...

2013-11-26 16:24:43

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today the successful treatment of a child with recurrent diffuse intrinsic pontine gliosarcoma (DIPGGS) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Pediatric gliosarcoma (GS) is a rare variant of glioblastoma multiforme. The pontine location of this tumor is unusual, invariably fatal and successful treatment was not yet described in medical literature. The...

2013-11-26 16:24:41

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in children with recurrent high-grade glioma at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. There are no standard treatment recommendations for children with high-grade glioma after recurrence. New therapies are required for patients whose tumor recurs after...

2013-11-26 16:24:38

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it has presented the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in adult patients with recurrent glioblastoma multiforme (GBM) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. GBM accounts for 60% of the primary brain tumors in adults and represents the most frequently occurring and the most malignant form of such tumors. Treatment...

2013-11-26 16:24:37

HOUSTON, Nov. 26, 2013 /PRNewswire/ -- The Burzynski Clinic (BC) announced today that it made a presentation of the results of a phase II study of antineoplastons A10 and AS2-1 (ANP) in pediatric recurrent diffuse intrinsic pontine glioma (DIPG) at the 4(th) Quadrennial Meeting of the World Federation of Neuro-Oncology in San Francisco. Brainstem gliomas are rare tumors in which DIPG comprises a distinct group. Numerous trials have been conducted in DIPG without proving...

2013-08-14 23:25:07

Lung Cancer Patient Now Cancer Free After Alternative Therapies at Sunridge Medical (PRWEB) August 14, 2013 In December of 2012, Patricia was diagnosed with Lung cancer and underwent surgery to remove part of her lung. After finding the cancer was also in her lymph nodes, her surgery was followed by chemotherapy and radiation. Feeling sick and weak from the treatments, Patricia, a resident of Idaho, said she felt like she was dying. Her doctors were also losing faith. “We had very...

2013-03-07 08:25:49

Screening to take place at the San Luis Obispo International Film Festival on March 10 SAN LUIS OBISPO, Calif., March 7, 2013 /PRNewswire/ -- In the compelling follow-up to the internationally award-winning documentary, Burzynski, the Movie; Burzynski: Cancer is Serious Business, Part II explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration -- and features a modern story of the struggling journeys of cancer...

2012-06-26 06:21:03

(Ivanhoe Newswire) —Blood tests that measure Vitamin D deficiency are among the most frequently ordered tests in medicine. A new study found that some test kits are inaccurate. Researchers at Loyola University Chicago Stritch School of Medicine found that two new tests, Abbot Architect and Siemans Centaur2, may not be accurate. This study was performed on 163 randomly selected blood samples. In 40% of the Abbott Architect specimens and 48% of the Siemans Centaur2 specimens, results...